Your account is not claimed yet. You can sign up with ORCID to claim your account.

Teresa Gagliano

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Cancer gene therapy

Oncogene

Cancers

Life (Basel, Switzerland)

Università degli Studi di Udine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Udine May 1o 2020

Italy

TENURE-TRACK ASSISTANT PROFESSOR :: DIPARTIMENTO AREA MEDICA

Publications

Eleonora Malavasi, Georgios Giamas, Teresa Gagliano
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment. Cancer gene therapy (2023)
Eleonora Malavasi, Georgios Giamas, Teresa Gagliano
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment. Cancer gene therapy (2023)
Eleonora Malavasi, Georgios Giamas, Teresa Gagliano
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment. Cancer gene therapy (2023)
Eleonora Malavasi, Georgios Giamas, Teresa Gagliano
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment. Cancer gene therapy (2023)
Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9. Life (Basel, Switzerland) 11 (2) (2021)
Teresa Gagliano, Claudio Brancolini
Epigenetic Mechanisms beyond Tumour-Stroma Crosstalk. Cancers 13 (4) (2021)
Georgios Giamas, Teresa Gagliano
Cancer gene therapy 2020: highlights from a challenging year. Cancer gene therapy (2021)
Teresa Gagliano, Claudio Brancolini
Targeting histone deacetylases for combination therapies in neuroendocrine tumors. Cancer gene therapy 28 (6) (2020)
Kalpit Shah, Teresa Gagliano, Lisa Garland, Timothy O'Hanlon, Daria Bortolotti, Valentina Gentili, Roberta Rizzo, Georgios Giamas, Michael Dean
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing. Oncogene 39 (39) (2020)

Teresa Gagliano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Teresa Gagliano